Clinical trial
Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage…
NCT00295867 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00295867 |
|---|---|
| Title | Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer |
| Official title | Pilot Study to Evaluate the Effect of Zoledronic Acid (Zometa) on Occult Malignant Bone Marrow Cells in Patients With High Risk Early Stage Breast Cancer |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Zoledronic Acid |
| Enrollment | 45 |
| Start date | Nov 3, 2004 |
| Primary completion | Jun 1, 2011 |
| Completion | Dec 1, 2013 |
| First posted | Feb 24, 2006 |
| Last update posted | May 12, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: